These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20398158)

  • 1. How can rates of prostate-specific antigen screening be reduced in men aged 80 and older?
    Whittle J; Zablocki CJ
    J Am Geriatr Soc; 2010 Apr; 58(4):757-9. PubMed ID: 20398158
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen testing in the elderly: a hard habit to kick?
    Konety BR
    BJU Int; 2006 Jan; 97(1):4-5. PubMed ID: 16336317
    [No Abstract]   [Full Text] [Related]  

  • 3. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Bunting PS
    Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud].
    Praz V; Jichlinski P; Aymon D; Leisinger HJ
    Rev Med Suisse; 2005 Dec; 1(44):2840-2. PubMed ID: 16382715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening among Vietnamese in Hawaii.
    Nguyen LT; Withy K; Nguyen MM; Yamada S
    Hawaii Med J; 2003 Jul; 62(7):145-8. PubMed ID: 12971132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
    Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
    Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
    Kuo NW; Lin HC; Lee HC
    J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour markers: their use and misuse by clinicians.
    McGinley PJ; Kilpatrick ES
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):643-7. PubMed ID: 14629802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of PSA requests from general practitioners received by one Dublin hospital.
    McGing PG
    Ir Med J; 1998; 91(2):61-2. PubMed ID: 9617033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
    Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
    Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we ordering too many PSA tests? Prostate cancer diagnosis and PSA screening patterns for a single Veterans Affairs Medical Center.
    Richter F; Dudley AW; Irwin RJ; Sadeghi-Nejad H
    J Cancer Educ; 2001; 16(1):38-41. PubMed ID: 11270898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer among men 75 years of age or older.
    Barry MJ
    N Engl J Med; 2008 Dec; 359(24):2515-6. PubMed ID: 19073973
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA testing in office-based clinics: are we testing as much as we think?
    González HM; West B; Underwood W
    J Am Coll Surg; 2005 Dec; 201(6):906-12. PubMed ID: 16310694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.